Health· 2 hours agoFDA Approves Pirtobrutinib for Newly Diagnosed CLL After a Trial Showed an 80% Lower Risk of ProgressionThe FDA has approved pirtobrutinib (Jaypirca) for adults with previously untreated chronic lymphocytic leukemia, after a 282-patient trial found it cut the risk of progression or death by 80% compared with chemoimmunotherapy.
